Cardiovascular
-
Cardiovascular
FDA Approves New Device to Treat Moderate to Severe Chronic Heart Failure
First-in-class device addresses significant unmet medical need in heart failure, modulates strength of heart muscle contraction rather than rhythm.U.S. Food and Drug Administration 03.22.19
-
Cardiovascular | Diagnostics
FDA Clears Genetesis' CardioFlux Platform
Next-generation magnetocardiography and cloud computing enable rapid, non-invasive cardiac imaging in the emergency department.Business Wire 03.22.19
-
Cardiovascular | Diagnostics
Toilet Seat Detects Congestive Heart Failure
Researchers developed the seats to measure biometrics during “natural” processes.Rochester Institute of Technology 03.21.19
-
Cardiovascular | Packaging & Sterilization | Surgical
Why Does Medtech Rely on Metal Finishing?
What is so important about using a metal finish, at least when it comes to cleanliness and sterilization?Online Exclusives Megan Ray Nichols, Science Writer; Editor, Schooled By Science 03.20.19
-
Cardiovascular
AtriCure Enrolls First Patient in the ICE-AFIB Clinical Trial
Study will evaluate the safety and effectiveness of AtriCure’s cryoICE Ablation System for the treatment of Afib.Business Wire 03.20.19
-
Cardiovascular | Surgical
Late-Breaking Analyses from Landmark COAPT Trial Show Benefits of Abbott's MitraClip
Treatment with MitraClip resulted in significant and sustained long-term quality-of-life improvements compared to medical therapy.Abbott Laboratories 03.19.19
-
Cardiovascular
Cook Medical Receives FDA Approval for Aortic Dissection Device
Device provides physicians a less invasive alternative to open surgery for repair of Type B dissections of the descending thoracic aorta.Business Wire 03.19.19
-
Cardiovascular | Patient Monitoring
Study: Apple Watch May Help Flag Heart Rhythm Problems
The Apple Watch was able to detect AFib in a small group of people who had been alerted by the app as having an irregular heartbeat.American College of Cardiology 03.18.19
-
Cardiovascular
Study: CardioMEMS Sensor Reliably Safe, Cuts Hospitalizations by More than Half
Heart failure is among the top conditions that result in hospitalizations among people age 65 years and older.American College of Cardiology 03.18.19
-
Cardiovascular
Study: Medtronic's Antibiotic Envelope Markedly Cuts Risk of Cardiac Device-Related Infection
Roughly 1.5 million patients receive a cardiac implantable electronic device worldwide every year.American College of Cardiology 03.18.19
-
Cardiovascular
FDA Approves Industry's Smallest, Slimmest 3T Tachycardia Devices from BIOTRONIK
Long-lasting devices feature unique DX technology and enhanced automation of heart failure therapy.PR Newswire 03.15.19
-
Cardiovascular | Surgical
FDA Approves Expanded Indication for Abbott's MitraClip
MitraClip is now approved to help difficult-to-treat heart failure patients with clinically significant secondary mitral regurgitation.Abbott Laboratories 03.15.19
-
Cardiovascular | Surgical
FDA Approves BD's Venous Stent to Treat Iliofemoral Venous Occlusive Disease
Venovo Venous Stent proven safe and effective in iliac and femoral veins.PR Newswire 03.14.19
-
Cardiovascular | Surgical
Boston Scientific's Next-Gen WATCHMAN FLX LAA Closure Device Gains CE Mark
The company began a limited market release in Europe.Boston Scientific 03.13.19
-
Cardiovascular | Surgical
Medtronic's Covidien Pays $17.5M to Resolve Catheter Kickback Case
Covidien allegedly offered free or discounted practice development and market development support to physicians to induce purchases of vein ablation products.U.S. Department of Justice 03.12.19
-
Cardiovascular
Cardiac Stent Feature Trailer 2019
New polymers and design improvements are defining the next generation of coronary stents.Videos Michael Barbella, Managing Editor
-
Cardiovascular | Contract Manufacturing | Neurological | R&D & Design
Minimally Invasive Device Segments from Creganna Medical
Read about a variety of Minimally Invasive Device Solutions from Creganna Medical
-
Cardiovascular | Surgical
Edwards to Buy Corvia, Mitralign Assets
These two strategic transactions involve companies with structural heart disease technologies.PR Newswire 03.11.19
-
Cardiovascular
Abiomed Receives CE Mark for Impella Connect
Company is launching the product through a controlled roll-out at hospital sites with established heart recovery protocols.Business Wire 03.11.19
-
Cardiovascular
SynCardia Welcomes New CEO
Don Webber's demonstrated leadership as COO led to his promotion in January 2019 to the chief executive office.PR Newswire 03.08.19
